Nautilus Biotechnology, Inc.

Nautilus Biotechnology, Inc. (Nasdaq: NAUT) is a proteomics life sciences company that entered the public markets through its 2021 merger with Arya Sciences Acquisition Corp III, a blank-check vehicle sponsored by Perceptive Advisors that filed its S-1 registration statement in July 2020. Based in San Carlos, California, Nautilus is developing a single-molecule protein analysis platform designed to enable large-scale proteomics research spanning drug discovery, diagnostics, and basic science applications. The SPAC completed its combination with Nautilus and the combined company began trading on the Nasdaq Capital Market under the ticker NAUT in mid-2021. Visit SpacDesk to access the full transaction record, filings history, and sponsor data for NAUT and hundreds of other SPAC deals.